Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism

Hypoparathyroidism and osteoporosis can be treated with parathyroid hormone, but frequent injections are required. Here the authors develop a small-molecule agonist for the parathyroid hormone type I receptor that can be administered orally, and demonstrate its efficacy in rats.

Guardado en:
Detalles Bibliográficos
Autores principales: Tatsuya Tamura, Hiroshi Noda, Eri Joyashiki, Maiko Hoshino, Tomoyuki Watanabe, Masahiko Kinosaki, Yoshikazu Nishimura, Tohru Esaki, Kotaro Ogawa, Taiji Miyake, Shinichi Arai, Masaru Shimizu, Hidetomo Kitamura, Haruhiko Sato, Yoshiki Kawabe
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/26ff462ed34f4f31ab3d012ea2e86ed2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:26ff462ed34f4f31ab3d012ea2e86ed2
record_format dspace
spelling oai:doaj.org-article:26ff462ed34f4f31ab3d012ea2e86ed22021-12-02T16:57:03ZIdentification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism10.1038/ncomms133842041-1723https://doaj.org/article/26ff462ed34f4f31ab3d012ea2e86ed22016-11-01T00:00:00Zhttps://doi.org/10.1038/ncomms13384https://doaj.org/toc/2041-1723Hypoparathyroidism and osteoporosis can be treated with parathyroid hormone, but frequent injections are required. Here the authors develop a small-molecule agonist for the parathyroid hormone type I receptor that can be administered orally, and demonstrate its efficacy in rats.Tatsuya TamuraHiroshi NodaEri JoyashikiMaiko HoshinoTomoyuki WatanabeMasahiko KinosakiYoshikazu NishimuraTohru EsakiKotaro OgawaTaiji MiyakeShinichi AraiMasaru ShimizuHidetomo KitamuraHaruhiko SatoYoshiki KawabeNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Tatsuya Tamura
Hiroshi Noda
Eri Joyashiki
Maiko Hoshino
Tomoyuki Watanabe
Masahiko Kinosaki
Yoshikazu Nishimura
Tohru Esaki
Kotaro Ogawa
Taiji Miyake
Shinichi Arai
Masaru Shimizu
Hidetomo Kitamura
Haruhiko Sato
Yoshiki Kawabe
Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism
description Hypoparathyroidism and osteoporosis can be treated with parathyroid hormone, but frequent injections are required. Here the authors develop a small-molecule agonist for the parathyroid hormone type I receptor that can be administered orally, and demonstrate its efficacy in rats.
format article
author Tatsuya Tamura
Hiroshi Noda
Eri Joyashiki
Maiko Hoshino
Tomoyuki Watanabe
Masahiko Kinosaki
Yoshikazu Nishimura
Tohru Esaki
Kotaro Ogawa
Taiji Miyake
Shinichi Arai
Masaru Shimizu
Hidetomo Kitamura
Haruhiko Sato
Yoshiki Kawabe
author_facet Tatsuya Tamura
Hiroshi Noda
Eri Joyashiki
Maiko Hoshino
Tomoyuki Watanabe
Masahiko Kinosaki
Yoshikazu Nishimura
Tohru Esaki
Kotaro Ogawa
Taiji Miyake
Shinichi Arai
Masaru Shimizu
Hidetomo Kitamura
Haruhiko Sato
Yoshiki Kawabe
author_sort Tatsuya Tamura
title Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism
title_short Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism
title_full Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism
title_fullStr Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism
title_full_unstemmed Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism
title_sort identification of an orally active small-molecule pthr1 agonist for the treatment of hypoparathyroidism
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/26ff462ed34f4f31ab3d012ea2e86ed2
work_keys_str_mv AT tatsuyatamura identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT hiroshinoda identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT erijoyashiki identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT maikohoshino identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT tomoyukiwatanabe identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT masahikokinosaki identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT yoshikazunishimura identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT tohruesaki identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT kotaroogawa identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT taijimiyake identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT shinichiarai identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT masarushimizu identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT hidetomokitamura identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT haruhikosato identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
AT yoshikikawabe identificationofanorallyactivesmallmoleculepthr1agonistforthetreatmentofhypoparathyroidism
_version_ 1718382613735931904